icon

ANI Pharmaceuticals, Inc. (ANIP)

Pharmaceutical Preparations

Insiders

Type of OwnerSecurities OwnedAs Insider in other CompaniesDate Last Transaction
CEO, Dir, President, Vice Chairman1,213,60212012-01-25
Dir, HEAD OF R&D, COO-NOVITIUM OPS706,27202024-07-18
Dir520,56042012-03-30
PRESIDENT, CEO, Dir370,37802024-11-26
Dir349,93402018-05-14
Dir289,00302018-03-15
Dir287,38842012-03-30
Sr VP of Finance, Secy, CFO265,93222012-01-25
SVP - CORP. DEV., STRATEGY242,90502024-07-01
Dir206,55002010-03-31
Dir, CEO, President190,30902020-04-06
SVP, CFO154,46802024-12-17
Dir123,24002012-03-30
PROD DEV, SVP OPS117,82902024-06-07
SVP, GENERICS77,22702024-06-05
HEAD OF RARE DISEASE76,77702024-11-15
Dir74,71222024-05-21
SEC., SR. VP, GENERAL COUNSEL55,58802025-01-13
CFO, Vice President54,29802016-04-07
Dir51,52602024-05-21
CHIEF HR OFFICER, SVP49,05902024-12-11
Dir49,02102022-04-27
Quality, VP, Product Develop.48,11802014-05-22
Dir40,60912024-05-21
Dir38,56102023-05-23
Dir33,48612012-03-30
SVP, HEAD - ESTABLISHED BRANDS33,16912024-11-15
Dir31,03702024-05-21
Dir26,91402014-09-15
Dir22,62112024-05-21
Dir14,81112018-03-20
Dir14,30102019-03-28
Dir11,99302024-05-21
Dir2,50002016-04-07
Sr. VP of Medical Affairs002012-01-25

Securities owned over time

FebMarAprMayJunJulAugSepOctNovDecJan0200k400k600k800k1M1.2M• Simes Stephen M• Shanmugam Muthusamy• Sherwin Stephen A• Lalwani Nikhil• Marshbanks Tracy• Raynor Daniel• Sullivan Louis W• Donenberg Phillip B.• Gassert Chad• Kjaer Peter• Przybyl Arthur• Carey Stephen P.• Rosenow Edward C III• Marken James G.• Gutwerg Ori• Mutz Christopher• Walsh Patrick D• Cook Meredith• Arnold Charlotte C.• Haughey Thomas• Davis Krista• Brown Robert E. Jr• Jamnick Robert J.• Thoma Jeanne• Nash David• Potts John T Jr• Rowland Thomas Andrew• Pera Antonio R• Mangano Ross J• Tannenbaum Renee P• Holubow Fred• Penn Thomas A.• Leonard Matthew J• Lankau Peter A• Snabes Michael C−200k0200k−2M02MΔ SecuritiesΔ Cash

Recent trades

Transaction DateInsiderTitleFormTrade TypesΔ SecuritiesΔ CashOwned
2025-01-13Cook MeredithSEC., SR. VP, GENERAL COUNSEL4S−400$21.6K55.59K
2024-12-17Carey Stephen P.SVP, CFO4S−7,500$418.4K154.47K
2024-12-13Cook MeredithSEC., SR. VP, GENERAL COUNSEL4S−250$14.1K55.99K
2024-12-11Davis KristaCHIEF HR OFFICER, SVP4S−1,000$60K49.06K
2024-11-26Lalwani NikhilPRESIDENT, CEO, Dir4M, S−3,481$1.1M370.38K
2024-11-15Mutz ChristopherHEAD OF RARE DISEASE4S−6,500$375.1K76.78K
2024-11-15Rowland Thomas AndrewSVP, HEAD - ESTABLISHED BRANDS4F−867$033.17K
2024-11-13Cook MeredithSEC., SR. VP, GENERAL COUNSEL4S−250$15.3K56.24K
2024-10-14Cook MeredithSEC., SR. VP, GENERAL COUNSEL4S−250$14.3K56.49K
2024-09-13Cook MeredithSEC., SR. VP, GENERAL COUNSEL4S−250$14.2K56.74K
2024-09-12Davis KristaCHIEF HR OFFICER, SVP4F−1,486$050.06K
2024-09-08Lalwani NikhilPRESIDENT, CEO, Dir4F−3,646$0373.86K
2024-08-13Cook MeredithSEC., SR. VP, GENERAL COUNSEL4S−250$14.9K56.99K
2024-07-18Cook MeredithSEC., SR. VP, GENERAL COUNSEL4F−1,743$057.24K
2024-07-18Shanmugam MuthusamyDir, HEAD OF R&D, COO-NOVITIUM OPS4S−2,743$170.1K706.27K
2024-07-15Shanmugam MuthusamyDir, HEAD OF R&D, COO-NOVITIUM OPS4S−47,257$3M709.02K
2024-07-12Cook MeredithSEC., SR. VP, GENERAL COUNSEL4S−250$16.2K58.98K
2024-07-01Gassert ChadSVP - CORP. DEV., STRATEGY4S−20,000$1.3M242.91K
2024-06-21Shanmugam MuthusamyDir, HEAD OF R&D, COO-NOVITIUM OPS4S−20,000$1.2M756.27K
2024-06-17Shanmugam MuthusamyDir, HEAD OF R&D, COO-NOVITIUM OPS4S−30,000$1.8M776.27K
2024-06-13Cook MeredithSEC., SR. VP, GENERAL COUNSEL4S−250$16K59.23K
2024-06-07Marken James G.PROD DEV, SVP OPS4F, M1,463-$661.4K117.83K
2024-06-05Gutwerg OriSVP, GENERICS4S−2,985$200K77.23K
2024-06-04Carey Stephen P.SVP, CFO4S−5,000$317.9K161.97K
2024-06-03Gassert ChadSVP - CORP. DEV., STRATEGY4S−20,000$1.3M262.91K
2024-05-21Mutz ChristopherHEAD OF RARE DISEASE4S−2,000$123.2K83.28K
2024-05-21Thoma JeanneDir4A4,410$040.61K
2024-05-21Leonard Matthew JDir4A4,410$011.99K
2024-05-21Walsh Patrick DDir4A4,410$074.71K
2024-05-21Pera Antonio RDir4A4,410$031.04K
2024-05-21Tannenbaum Renee PDir4A4,410$022.62K
2024-05-21Haughey ThomasDir4A4,410$051.53K
2024-05-20Shanmugam MuthusamyDir, HEAD OF R&D, COO-NOVITIUM OPS4S−12,855$794.6K806.27K
2024-05-16Tannenbaum Renee PDir4S−2,000$127.7K18.21K
2024-05-15Shanmugam MuthusamyDir, HEAD OF R&D, COO-NOVITIUM OPS4S−37,145$2.4M819.13K
2024-05-14Lalwani NikhilPRESIDENT, CEO, Dir4S−16,669$1.1M377.51K
2024-05-13Cook MeredithSEC., SR. VP, GENERAL COUNSEL4S−250$16.9K59.48K
2024-05-01Gassert ChadSVP - CORP. DEV., STRATEGY4S−20,000$1.3M282.91K
2024-04-18Shanmugam MuthusamyDir, HEAD OF R&D, COO-NOVITIUM OPS4S−27,232$1.8M856.27K
2024-04-15Shanmugam MuthusamyDir, HEAD OF R&D, COO-NOVITIUM OPS4S−22,768$1.5M883.5K
2024-04-12Cook MeredithSEC., SR. VP, GENERAL COUNSEL4S−250$16.9K59.73K
2024-04-10Carey Stephen P.SVP, CFO4F−4,534$0166.97K
2024-04-10Marken James G.PROD DEV, SVP OPS4F−2,799$0116.01K
2024-04-01Gassert ChadSVP - CORP. DEV., STRATEGY4S−20,000$1.3M302.91K
2024-03-23Lalwani NikhilPRESIDENT, CEO, Dir4F−17,455$0394.17K
2024-03-23Carey Stephen P.SVP, CFO4F−6,210$0171.5K
2024-03-23Marken James G.PROD DEV, SVP OPS4F−3,653$0118.81K
2024-03-18Rowland Thomas AndrewSVP, HEAD - ESTABLISHED BRANDS30$034.04K
2024-03-13Cook MeredithSEC., SR. VP, GENERAL COUNSEL4S−250$16.6K59.98K
2024-03-11Gassert ChadSVP - CORP. DEV., STRATEGY4S−20,000$1.3M322.91K
2024-03-08Shanmugam MuthusamyDir, HEAD OF R&D, COO-NOVITIUM OPS4S−10,000$671.7K906.27K
2024-03-07Mutz ChristopherHEAD OF RARE DISEASE4F−2,110$085.28K
2024-03-07Gutwerg OriSVP, GENERICS4F−2,494$080.21K
2024-03-07Carey Stephen P.SVP, CFO4F, S−12,003$510.4K177.71K
2024-03-07Marken James G.PROD DEV, SVP OPS4F, S−26,372$1.6M122.46K
2024-03-06Lalwani NikhilPRESIDENT, CEO, Dir4F, S−62,317$3M411.63K
2024-03-05Shanmugam MuthusamyDir, HEAD OF R&D, COO-NOVITIUM OPS4S−40,000$2.6M916.27K
2024-03-05Mutz ChristopherHEAD OF RARE DISEASE4S−5,000$330K87.39K
2024-03-04Pera Antonio RDir4S−7,000$456.4K26.63K
2024-02-29Davis KristaCHIEF HR OFFICER, SVP4F−1,173$051.55K
2024-02-29Cook MeredithSEC., SR. VP, GENERAL COUNSEL4F−1,173$060.23K
2024-02-29Gassert ChadSVP - CORP. DEV., STRATEGY4F−1,635$0342.91K
2024-02-29Shanmugam MuthusamyDir, HEAD OF R&D, COO-NOVITIUM OPS4F−1,122$0956.27K
2024-02-29Mutz ChristopherHEAD OF RARE DISEASE4F−1,275$092.39K
2024-02-29Gutwerg OriSVP, GENERICS4F−1,570$082.71K
2024-02-29Lalwani NikhilPRESIDENT, CEO, Dir4F−10,014$0473.95K
2024-02-29Carey Stephen P.SVP, CFO4F−1,914$0189.72K
2024-02-29Marken James G.PROD DEV, SVP OPS4F−1,058$0148.83K
2024-02-15Mutz ChristopherHEAD OF RARE DISEASE4F−1,261$093.66K
2024-02-15Gutwerg OriSVP, GENERICS4F−1,244$084.28K
2024-02-14Davis KristaCHIEF HR OFFICER, SVP4A20,131$052.72K
2024-02-14Cook MeredithSEC., SR. VP, GENERAL COUNSEL4A24,605$061.4K
2024-02-14Gassert ChadSVP - CORP. DEV., STRATEGY4A22,367$0344.54K
2024-02-14Shanmugam MuthusamyDir, HEAD OF R&D, COO-NOVITIUM OPS4A22,367$0957.39K
2024-02-14Mutz ChristopherHEAD OF RARE DISEASE4A31,316$094.92K
2024-02-14Gutwerg OriSVP, GENERICS4A24,605$085.52K
2024-02-14Lalwani NikhilPRESIDENT, CEO, Dir4A134,216$0483.96K
2024-02-14Carey Stephen P.SVP, CFO4A35,790$0191.63K
2024-02-14Marken James G.PROD DEV, SVP OPS4A16,776$0149.89K
2024-02-13Cook MeredithSEC., SR. VP, GENERAL COUNSEL4S−250$14K36.8K
2024-01-19Shanmugam MuthusamyDir, HEAD OF R&D, COO-NOVITIUM OPS4S−25,216$1.4M935.03K
2024-01-16Shanmugam MuthusamyDir, HEAD OF R&D, COO-NOVITIUM OPS4S−24,784$1.4M960.24K

Splits

DateRatio
2013-07-186:1